News Focus
News Focus
icon url

cheynew

08/29/16 2:19 PM

#271121 RE: Dragon Lady #271120

I think the following quote is also important:

"In addition, most of our competitors may have substantially greater financial, marketing, technical or other resources than we do. Moreover, additional competition may emerge and may, among other things, result in a decrease in the fees paid for our services, which would affect our results of operations "
icon url

NoMoDo

08/29/16 2:21 PM

#271122 RE: Dragon Lady #271120

Good speculation. PPHM has contract backlogs for more revenue than they were able to produce this year. Still, you never know what COULD happen...

California could fall into the ocean too. They have been talking about it for decades. I think I will spend this week researching all California companies and start shorting them.

icon url

hopefilled2014

08/29/16 3:14 PM

#271129 RE: Dragon Lady #271120

This has to be FREAKING insider information. Where do you get it?

OR, OR, OR, they could lose just ONE, ONE, ONE key customer, a highly speculative, high risk start-up in and of themselves, and they'd be close to ZERO revenues and no backlog and have a facility sitting empty with a bloated staff sucking down cash, looking to mop the floors one more time or send an email to someone.


I cannot LOL LOL this at all. Well done!
icon url

TampaTradr

08/29/16 4:09 PM

#271136 RE: Dragon Lady #271120

The Balance Sheet disagrees with your "guess" of lil ole PPHM's assets.......



33,912,000
Less accumulated depreciation (9,610,000)

Property and equipment, net 24,302,000
icon url

itsabouttime

08/29/16 5:39 PM

#271159 RE: Dragon Lady #271120

Hornet Keep us in focus so none of us goes hog wild and buys up thousand of shares with out examining these PR'S more thoroughly.
icon url

BCS Paladin

08/29/16 7:46 PM

#271169 RE: Dragon Lady #271120

Nice business model huh?

During fiscal years 2016, 2015 and 2014, Avid’s total revenue generated from third-party customers amounted to $44,357,000, $26,744,000, and $22,294,000, respectively, of which 69%, 79% and 91%, respectively, was derived from Halozyme Therapeutics, Inc. [color=red][/color]